BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19834109)

  • 1. Bone marrow AT1 augments neointima formation by promoting mobilization of smooth muscle progenitors via platelet-derived SDF-1{alpha}.
    Yokoi H; Yamada H; Tsubakimoto Y; Takata H; Kawahito H; Kishida S; Kato T; Matsui A; Hirai H; Ashihara E; Maekawa T; Iwai M; Horiuchi M; Ikeda K; Takahashi T; Okigaki M; Matsubara H
    Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):60-7. PubMed ID: 19834109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells.
    Zernecke A; Schober A; Bot I; von Hundelshausen P; Liehn EA; Möpps B; Mericskay M; Gierschik P; Biessen EA; Weber C
    Circ Res; 2005 Apr; 96(7):784-91. PubMed ID: 15761195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SDF-1alpha involved in mobilization and recruitment of endothelial progenitor cells after arterial injury in mice.
    Yin Y; Zhao X; Fang Y; Yu S; Zhao J; Song M; Huang L
    Cardiovasc Pathol; 2010; 19(4):218-27. PubMed ID: 19502087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation.
    Zhang LN; Wilson DW; da Cunha V; Sullivan ME; Vergona R; Rutledge JC; Wang YX
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):765-72. PubMed ID: 16456092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow angiotensin AT1 receptor regulates differentiation of monocyte lineage progenitors from hematopoietic stem cells.
    Tsubakimoto Y; Yamada H; Yokoi H; Kishida S; Takata H; Kawahito H; Matsui A; Urao N; Nozawa Y; Hirai H; Imanishi J; Ashihara E; Maekawa T; Takahashi T; Okigaki M; Matsubara H
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1529-36. PubMed ID: 19628784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice.
    Schober A; Knarren S; Lietz M; Lin EA; Weber C
    Circulation; 2003 Nov; 108(20):2491-7. PubMed ID: 14581398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation.
    Subramanian P; Karshovska E; Reinhard P; Megens RT; Zhou Z; Akhtar S; Schumann U; Li X; van Zandvoort M; Ludin C; Weber C; Schober A
    Circ Res; 2010 Jul; 107(1):96-105. PubMed ID: 20360252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice.
    Karshovska E; Zernecke A; Sevilmis G; Millet A; Hristov M; Cohen CD; Schmid H; Krotz F; Sohn HY; Klauss V; Weber C; Schober A
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2540-7. PubMed ID: 17932320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
    Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S
    Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate.
    Wang CH; Anderson N; Li SH; Szmitko PE; Cherng WJ; Fedak PW; Fazel S; Li RK; Yau TM; Weisel RD; Stanford WL; Verma S
    Circ Res; 2006 Sep; 99(6):617-25. PubMed ID: 16931795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner.
    Salguero G; Akin E; Templin C; Kotlarz D; Doerries C; Landmesser U; Grote K; Schieffer B
    J Hypertens; 2008 Feb; 26(2):257-68. PubMed ID: 18192840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
    Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of BM SDF-1 by MMP-9: the role in G-CSF-induced hematopoietic stem/progenitor cell mobilization.
    Jin F; Zhai Q; Qiu L; Meng H; Zou D; Wang Y; Li Q; Yu Z; Han J; Li Q; Zhou B
    Bone Marrow Transplant; 2008 Nov; 42(9):581-8. PubMed ID: 18679363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of stromal cell-derived factor and its receptor-CXCR4 in G-CSF-induced hematopoietic stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):98-102. PubMed ID: 17650669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis.
    Sakihama H; Masunaga T; Yamashita K; Hashimoto T; Inobe M; Todo S; Uede T
    Circulation; 2004 Nov; 110(18):2924-30. PubMed ID: 15505104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing.
    Fiorina P; Pietramaggiori G; Scherer SS; Jurewicz M; Mathews JC; Vergani A; Thomas G; Orsenigo E; Staudacher C; La Rosa S; Capella C; Carothers A; Zerwes HG; Luzi L; Abdi R; Orgill DP
    Cell Transplant; 2010; 19(11):1369-81. PubMed ID: 20977829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia.
    Urao N; Okigaki M; Yamada H; Aadachi Y; Matsuno K; Matsui A; Matsunaga S; Tateishi K; Nomura T; Takahashi T; Tatsumi T; Matsubara H
    Circ Res; 2006 Jun; 98(11):1405-13. PubMed ID: 16645141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment.
    Tang YL; Qian K; Zhang YC; Shen L; Phillips MI
    Regul Pept; 2005 Feb; 125(1-3):1-8. PubMed ID: 15582707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury.
    Iwakura A; Luedemann C; Shastry S; Hanley A; Kearney M; Aikawa R; Isner JM; Asahara T; Losordo DW
    Circulation; 2003 Dec; 108(25):3115-21. PubMed ID: 14676142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.